Medical and Pharmaceutical Industry Technology and Development Center
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Mar 12 to 29, 2027 · next Mar 12
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,842,318 | Use of a potent product extracted from rhizomes of Zingiber officinale in treating a disease associated with Helicobacter pylori In force · USPTO record | In force | USPTO record | |
| US 8,470,379 | Use of a potent product extracted from rhizomes of zingiber officinale in treating a disease associated with Helicobacter pylori In force · USPTO record | In force | USPTO record | |
| US 7,531,519 | Polygalatenosides and use thereof as an antidepressant agent In force · USPTO record | In force | USPTO record | |
| US 7,771,745 | Fast dissolving tablet and method of preparing the same In force · USPTO record | In force | USPTO record | |
| US 8,071,142 | Anti-bacterial use of extract from Morus australis poir. and compound kuwanon h In force · USPTO record | In force | USPTO record | |
| US 8,257,759 | Antitussive composition and method for making the same In force · USPTO record | In force | USPTO record | |
| US 9,144,590 | Use of aster extract in the treatment of opioid-induced constipation In force · USPTO record | In force | USPTO record | |
| US 10,940,113 | Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof In force · USPTO record | In force | USPTO record | |
| US 11,752,104 | Oral composition and methods for manufacturing the same and treatment In force · USPTO record | In force | USPTO record | |
| US 11,759,471 | Modified release pharmaceutical composition and method for the treatment of mental disorders In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 10: 4 lapsed for an unpaid fee · 7 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 no status recorded